In preeclampsia endogenous cardiotonic steroids induce vascular fibrosis and impair relaxation of umbilical arteries

Journal of Hypertension

Volumn 29, Issue 4, 2011, Pages 769-776

  Nikitina, Elena R ^b   Mikhailov, Anton V ^c   Nikandrova, Ekaterina S ^c   Frolova, Elena V ^b   Fadeev, Artem V ^b   Shman, Vera V ^c   Shilova, Victoria Y ^a   Tapilskaya, Natalia I ^e   Shapiro, Joseph I ^d   Fedorova, Olga V ^a   Bagrov, Alexei Y ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

^c ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^d MEDICAL COLLEGE OF OHIO   (United States)

^e School of Pediatric Medicine   (Russian Federation)

Author keywords

collagen; digitalis like factor; endothelium independent vasorelaxation; fibrosis; Fli 1; marinobufagenin; Na K ATPase; preeclampsia; umbilical arteries

Indexed keywords

COLLAGEN TYPE 1; ENDOTHELIN 1; MARINOBUFAGENIN; NITROPRUSSIDE SODIUM; PROCOLLAGEN; PROCOLLAGEN 1; TRANSCRIPTION FACTOR FLI 1; UNCLASSIFIED DRUG;

ADULT; ARTERIAL STIFFNESS; ARTERY DILATATION; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; FETUS CIRCULATION; HUMAN; HUMAN TISSUE; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL ARTERY; VASCULAR FIBROSIS;

EID: 79952775507     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834436a7     Document Type: Article

References (33)

1. Sibai B, Dekker G, Kupferminc M. Preeclampsia. Lancet 2005; 365:785-799.
2. Wang A, Rana S, Karumanchi SA. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda) 2009; 24:147-158.
3. Bagrov AY, Shapiro JI. Endogenous digitalis: pathophysiologic roles and therapeutic applications. Nat Clin Pract Nephrol 2008; 4:378-392. (Pubitemid 351913708)
4. Gusdon JP Jr, Buckalew VM Jr, Hennessy JF. A digoxin-like immunoreactive substance in preeclampsia. Am J Obstet Gynecol 1984; 150:83-85. (Pubitemid 14074605)
5. Graves SW, Valdes R Jr, Brown BA, Knight AB, Craig HR. Endogenous digoxin-immunoreactive substance in human pregnancies. J Clin Endocrinol Metab 1984; 58:748-751. (Pubitemid 14137275)
6. Goodlin RC. Antidigoxin antibodies in eclampsia. N Engl J Med 1988; 318:518-559.
7. Adair CD, Buckalew V, Taylor K, Ernest JM, Frye AH, Evans C, Veille JC. Elevated endoxin-like factor complicating a multifetal second trimester pregnancy: treatment with digoxin-binding immunoglobulin. Am J Nephrol 1996; 16:529-531. (Pubitemid 26387940)
8. Adair CD, Luper A, Rose JC, Russell G, Veille JC, Buckalew VM. The hemodynamic effects of intravenous digoxin-binding fab immunoglobulin in severe preeclampsia: a double-blind, randomized, clinical trial. J Perinatol 2009; 29:284-289.
9. Lopatin DA, Ailamazian EK, Dmitrieva RI, Shpen VM, Fedorova OV, Doris PA, Bagrov AY. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. J Hypertens 1999; 17:1179-1187. (Pubitemid 29389566)
10. Averina IV, Tapilskaya NI, Reznik VA, Frolova EV, Fedorova OV, Lakatta EG, Bagrov AY. Endogenous Na/K-ATPase inhibitors in patients with preeclampsia. Cell Mol Biol (Noisy-le-grand) 2006; 52:19-23. (Pubitemid 46799700)
11. Fedorova OV, Simbirtsev AS, Kolodkin NI, Kotov AY, Agalakova NI, Kashkin VA, et al. Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension. J Hypertens 2008; 26:2414-2425.
12. Fedorova OV, Kolodkin NI, Agalakova NI, Namikas AR, Bzhelyansky A, St-Louis J, et al. Antibody to marinobufagenin lowers blood pressure in pregnant rats on a high NaCl intake. J Hypertens 2005; 23:835-842. (Pubitemid 40523283)
13. Kennedy DJ, Vetteth S, Periyasamy SM, Kanj M, Fedorova L, Khouri S, et al. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension 2006; 47:488-495. (Pubitemid 43740295)
14. Elkareh J, Kennedy DJ, Yashaswi B, Vetteth S, Shidyak A, Kim EG, et al. Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy. Hypertension 2007; 49:215-224. (Pubitemid 46360363)
15. Elkareh J, Periyasamy SM, Shidyak A, Vetteth S, Schroeder J, Raju V, et al. Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy. Am J Physiol Renal Physiol 2009; 296:F1219-F1226.
16. Tihtonen KM, Kööbi T, Uotila JT. Arterial stiffness in preeclamptic and chronic hypertensive pregnancies. Eur J Obstet Gynecol Reprod Biol 2006; 128:180-186. (Pubitemid 44311336)
17. Kaihura C, Savvidou MD, Anderson JM, McEniery CM, Nicolaides KH. Maternal arterial stiffness in pregnancies affected by preeclampsia. Am J Physiol Heart Circ Physiol 2009; 297:H759-H764.
18. National Institutes of Health Working Group on Hypertension in Pregnancy. Classification of hypertensive disorders of pregnancy. Bethesda, MD, US Dept. of Health and Human Services; 1991.
19. Fedorova OV, Dorofeeva NA, Lopatin DA, Lakatta EG, Bagrov AY. Phorbol diacetate potentiates Na/K-ATPase inhibition by a putative endogenous ligand, marinobufagenin. Hypertension 2002; 39:298-302. (Pubitemid 34165232)
20. Bagrov AY, Fedorova OV, Austin-Lane JL, Dmitrieva RI, Anderson DE. Endogenous marinobufagenin-like immunoreactive factor and Na,KATPase inhibition during voluntary hypoventilation. Hypertension 1995; 26:781-788.
21. Romanowicz L, Bań kowski E. Preeclampsia-associated alterations in sphingolipid composition of the umbilical cord artery. Clin Biochem 2009; 42:1719-1724.
22. Takase B, Goto T, Hamabe A, Uehata A, Kuroda K, Satomura K, et al. Flow-mediated dilation in brachial artery in the second half of pregnancy and prediction of preeclampsia. J Hum Hypertens 2003; 17:697-704. (Pubitemid 37265146)
23. Uchida N, Mori A, Togo A, Ishiguro Y, Mikami M. Uteroplacental circulation, preeclampsia, and maternal abdominal aortic stiffness in normal and compromised pregnancies. J Perinat Med 2007; 35:119-125.
24. Robb AO, Mills NL, Din JN, Smith IB, Paterson F, Newby DE, Denison FC. Influence of the menstrual cycle, pregnancy, and preeclampsia on arterial stiffness. Hypertension 2009; 53:952-958.
25. Xavier FE, Yogi A, Callera GE, Tostes RC, Alvarez Y, Salaices M, et al. Contribution of the endothelin and renin-angiotensin systems to the vascular changes in rats chronically treated with ouabain. Br J Pharmacol 2004; 143:794-802. (Pubitemid 39611615)
26. Wynne BM, Chiao CW, Webb RC. Vascular smooth muscle cell signaling mechanisms for contraction to angiotensin II and endothelin-1. J Am Soc Hypertens 2009; 3:84-95.
27. Gu Y, Lewis DF, Wang Y. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies. J Clin Endocrinol Metab 2008; 93:260-266.
28. Vu HV, Ianosi-Irimie MR, Pridjian CA, Whitbred JM, Durst JM, Bagrov AY, et al. Involvement of marinobufagenin in a rat model of human preeclampsia. Am J Nephrol 2005; 25:520-528. (Pubitemid 41433898)
29. Ong SS, Crocker IP, Warren AY, Baker PN. Functional characteristics of chorionic plate placental arteries from normal pregnant women and women with preeclampsia. Hypertens Pregnancy 2002; 21:175-283.
30. Sexton AJ, Loesch A, Turmaine M, Miah S, Burnstock G. Nitric oxide and human umbilical vessels: pharmacological and immunohistochemical studies. Placenta 1995; 16:277-288.
31. Izumi H, Garfield RE, Makino Y, Shirakawa K, Itoh T. Gestational changes in endothelium-dependent vasorelaxation in human umbilical artery. Am J Obstet Gynecol 1994; 170:236-245. (Pubitemid 24084060)
32. Nakerakanti SS, Kapanadze B, Yamasaki M, Markiewicz M, Trojanowska M. Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program. J Biol Chem 2006; 281:25259-25269. (Pubitemid 44401913)
33. Wang Y, Fan PS, Kahaleh B. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheum 2006; 54:2271-2279. (Pubitemid 44051084)